Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer. A Pilot Study

NCT05222087 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.

NCT NCT05222087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer. A Pilot Study
Lead sponsor
Peter MacCallum Cancer Centre, Australia
Phase
Phase 1
Overall status
Recruiting
Start date
January 3, 2022
Completion date
April 30, 2025
Enrollment
40 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc